Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Homogenization and Cell Lysis01:32

Tissue Homogenization and Cell Lysis

10.1K
Tissue homogenization involves disintegrating tissue architecture and lysing cells, and is an early step in isolating and analyzing cellular components. The method used for homogenization depends on the sample type, the amount of sample available, the analyte to be obtained, and the sensitivity of the method. These methods are broadly classified as mechanical and non-mechanical methods.
Mechanical methods of tissue homogenization
These methods rely on applying external physical force to disrupt...
10.1K
What is the Immune System?01:38

What is the Immune System?

127.2K
Overview
127.2K
Humoral Immune Responses01:36

Humoral Immune Responses

83.5K
Overview
83.5K
Design Example: Creating a Hydraulic Model of a Dam Spillway01:21

Design Example: Creating a Hydraulic Model of a Dam Spillway

705
Scaled hydraulic models of dam spillways provide a practical way to replicate and study the intricate flow dynamics of these structures. Often built to a 1:15 ratio, these models allow for observing critical water behavior, such as velocity distribution, flow patterns, and energy dissipation.
705
Active versus Passive Immunity01:31

Active versus Passive Immunity

10.1K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
10.1K
Introduction to Lymphatic and Immune System01:22

Introduction to Lymphatic and Immune System

16.7K
Immunity is a crucial biological concept about our body's inherent capacity to prevent infections and diseases. A complex network of cells and tissues collectively known as the immune system facilitates this natural defense mechanism. The immune system plays an integral role in maintaining our health and well-being, shielding us from potential health threats.
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are...
16.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Nature medicine·2026
Same author

Hierarchical endpoints and win statistics for geromedicine trials.

Nature aging·2026
Same author

Cell stress and death liberate the autophagy-inhibitory tissue stress hormone DBI/ACBP into the circulation.

Autophagy·2026
Same author

Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.

Journal for immunotherapy of cancer·2026
Same author

Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulation.

Cell death and differentiation·2026
Same author

Spermine is an endogenous iron chelator that inhibits ferroptosis.

Nature·2026

Related Experiment Video

Updated: Jan 24, 2026

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.4K

Tumor lysis with LTX-401 creates anticancer immunity.

Wei Xie1,2,3,4, Laura Mondragón1,2,3,4, Brynjar Mauseth5,6,7

  • 1Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.

Oncoimmunology
|May 31, 2019
PubMed
Summary

Local immunotherapy with LTX-401 cures cancer in mice by enhancing immune memory. Combining LTX-401 with immune checkpoint blockade (ICB) demonstrated significant abscopal effects against distant tumors.

Keywords:
Oncolysisanticancer therapycheckpoint blockadeimmunogenic cell death

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.5K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.4K

Related Experiment Videos

Last Updated: Jan 24, 2026

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.4K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.5K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.4K

Area of Science:

  • Oncology
  • Immunotherapy
  • Cancer Research

Background:

  • Local immunotherapies, including oncolytic compounds, aim to boost systemic anticancer immunity.
  • LTX-315 is a clinically evaluated oncolytic peptide for local immunotherapy.
  • LTX-401 is a novel oncolytic compound developed for local immunotherapy.

Purpose of the Study:

  • To evaluate the safety and efficacy of LTX-401 as a local immunotherapy.
  • To assess the potential of LTX-401 in inducing long-term immune memory.
  • To investigate the synergistic effects of LTX-401 with immune checkpoint blockade (ICB).

Main Methods:

  • Administered LTX-401 via sequential local inoculation in immunocompetent mice with subcutaneous MCA205 and TC-1 tumors.
  • Assessed tumor cure rates, long-term immune memory, and resistance to tumor rechallenge.
  • Evaluated the combination therapy of LTX-401 with PD-1 and CTLA-4 immune checkpoint blockade (ICB).

Main Results:

  • LTX-401 demonstrated a similar safety profile to LTX-315.
  • Sequential LTX-401 treatment led to complete tumor eradication and long-term immune memory in cured mice.
  • LTX-401 alone showed limited abscopal effects on contralateral tumors.
  • Combination therapy with LTX-401 and ICB significantly enhanced anticancer effects.
  • Sequential LTX-401 with dual ICB achieved potent abscopal effects on contralateral tumors.

Conclusions:

  • LTX-401 is a safe and effective local immunotherapy agent capable of inducing durable anticancer immunity.
  • Combination of LTX-401 with ICB, particularly dual ICB, represents a potent strategy for treating secondary and distant tumors.